%0 Journal Article %A Amy E Miles %A Fernanda C Dos Santos %A Enda M Byrne %A Miguel E Renteria %A Andrew M McIntosh %A Mark J Adams %A Giorgio Pistis %A Enrique Castelao %A Martin Preisig %A Bernhard T Baune %A K Oliver Schubert %A Cathryn M Lewis %A Lisa A Jones %A Ian Jones %A Rudolf Uher %A Jordan W Smoller %A Roy H Perlis %A Douglas F Levinson %A James B Potash %A Myrna M Weissman %A Jianxin Shi %A Glyn Lewis %A Brenda WJH Penninx %A Dorret I Boomsma %A Steven P Hamilton %A Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium %A Etienne Sibille %A Ahmad R Hariri %A Yuliya S Nikolova %T Novel polygenic risk score links depression-related cortical transcriptomic changes to brain morphology and symptom severity %D 2021 %R 10.1101/2021.02.28.21251786 %J medRxiv %P 2021.02.28.21251786 %X Our group developed a transcriptome-based polygenic risk score (T-PRS) that uses common genetic variants to capture ‘depression-like’ shifts in cortical gene expression. Here, we mapped T-PRS onto diagnosis and symptom severity in major depressive disorder (MDD) cases and controls from the Psychiatric Genomics Consortium (PGC). To evaluate potential mechanisms, we further mapped T-PRS onto discrete measures of brain morphology and broad depression risk in healthy young adults. Genetic, self-report, and/or neuroimaging data were available in 29,340 PGC participants (59% women; 12,923 MDD cases, 16,417 controls) and 482 participants in the Duke Neurogenetics Study (DNS: 53% women; aged 19.8±1.2 years). T-PRS was computed from SNP data using PrediXcan to impute cortical expression levels of MDD-related genes from a previous post-mortem transcriptome meta-analysis. Sex-specific regressions were used to test effects of T-PRS on depression diagnosis, symptom severity, and Freesurfer-derived subcortical volume, cortical thickness, surface area, and local gyrification index in the PGC and DNS samples, respectively. T-PRS did not predict depression diagnosis (OR=1.007, 95%CI=[0.997-1.018]); however, it correlated with symptom severity in men (rho=0.175, p=7.957×10−4) in one large PGC cohort (N=762, 48% men). In DNS, T-PRS was associated with smaller amygdala volume in women (β=-0.186, t=-3.478, p=.001) and less prefrontal gyrification (max≤-2.970, p≤.006) in both sexes. In men, prefrontal gyrification mediated an indirect effect of T-PRS on broad depression risk (b=.005, p=.029), indexed using self-reported family history of depression. Depression-like shifts in cortical gene expression predict symptom severity in men and may contribute to disease vulnerability through their effect on cortical gyrification.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAEM is supported by a CAMH Discovery Fund Postdoctoral Fellowship. ARH received support from NIH grants R01DA033369 and R01AG049789. YSN is supported by a Koerner New Scientist Award administered by the CAMH Foundation, and a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant. The PGC has received major funding from the US National Institute of Mental Health (5 U01MH109528-03).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Duke University IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon reasonable request from the principal investigators. %U https://www.medrxiv.org/content/medrxiv/early/2021/04/13/2021.02.28.21251786.full.pdf